Company Overview and News
Cyient has announced that it has signed an exclusive software licensing agreement with Elpis Squared (Elpis) on Wednesday.
US Citizenship and Immigration Services (USCIS), the agency that oversees lawful immigration in the US, on Tuesday resumed premium processing for all types of H-1B visa petitions, a move that would be a positive for the Indian information technology industry.
Greaves Cotton Ltd (GCL) has entered into a strategic partnership with US & Bengaluru based startup – Altigreen Propulsion Labs. The partnership aims to provide a range of cost effective clean energy power train solutions for the 3-wheeler and micro 4-wheeler commercial vehicles.
Sun Pharmaceuticals, Natco Pharma, Dr Reddy’s Laboratories, Aurobindo Pharma, Cipla and Divi’s Laboratories were contributing majorly to the index gaining.
Unichem Laboratories has announced that it has received ANDA approval from the USFDA for Ibesartan and Hydrochlorothiazide Tablets .
Over one hundred companies will declare their April-June quarter results on Wednesday. These include 3M, Ajanta Pharma, Aurobindo Pharma, AU Small Finance Bank, Balmer Lawrie, City Union Bank, Eicher Motors, GMDC, Greenlam Industries, GTL Infra, Inox Wind, Jai Corp, Jindal Stainless, Max Fin, Nalco, NHPC, NMDC, PTC India Fin, P&S Bank, Sanghi Movers, Tata Motors, Tube Investments, Unichem Laboratories, VA Tech Wabag, Wheels India, Wonderla and West Coast Paper Mills.
Drug firm Unichem Laboratories today said it has received approval from the US health regulator for losartan potassium and hydrochlorothiazide, used in treatment of hypertension and reduction in risk of strokes in patients with hypertension.
Unichem Laboratories has received approval from the US health regulator for losartan potassium and hydrochlorothiazide tablets, used in the treatment of hypertension and reduction in risk of strokes in patients with hypertension.
Pharma major, Unichem Laboratories has received ANDA approval from the USFDA for Losartan Potassium and Hydrochlorothiazide tablets USP.
Unichem Laboratories shares gained nearly 4 percent intraday Tuesday after getting approval from the US health regulator for Losartan Potassium and Hydrochlorothiazide tablets USP, 50mg/12.5 mg, 100mg/12.5 mg and 100 mg/25 mg.
Post the implementation of the Goods & Services Tax (GST) in the country, a large amount of false information about GST has been circulating on various social media platforms.
BSE Sensex opened higher by 91 points at 31896, while the Nifty50 opened higher by 21 points at the 9807 mark.
Disclaimer: The contents herein is specifically prepared by ‘Dalal Street Investment Journal’, and is for your information & personal consumption only. India Infoline Limited or Dalal Street Investment Journal do not guarantee the accuracy, correctness, completeness or reliability of information contained herein and shall not be held responsible.
On the daily charts, the index has formed small bullish candle. Going forward, Nifty has to hold 9800 level for fresh upsurge towards 9900.
US equities surged on Wednesday as investors digested US Fed Reserve Head Janet Yellen testimony to Congress.
Unichem Laboratories has received Establishment Inspection Report (EIR) from the US health regulator for the company’s plant at Goa.
Drug firm Unichem Laboratories has received Establishment Inspection Report (EIR) from the US health regulator for the company's plant at Goa.
Unichem Laboratories soared over 3% at Rs 267.95 per share on BSE during Friday’s intraday trade.
Share price of Unichem Laboratories surged 6.5 percent intraday Friday as its Goa facility has received Establishment Inspection Report from USFDA.